Skip to main content

MDL Judge Dismisses 4 Paraquat Cases, Excludes Expert

MDL Judge Dismisses 4 Paraquat Cases, Excludes Expert

MDL Judge Dismisses 4 Paraquat Cases, Excludes Expert

Introduction

The U.S. District Judge overseeing the Paraquat Parkinson’s disease lawsuits has barred a key expert witness from testifying at trial, leading to the dismissal of four bellwether cases lacking the necessary support to proceed.

These cases are part of a larger litigation against Syngenta and Chevron, encompassing over 5,000 lawsuits alleging Paraquat exposure causes Parkinson’s disease. Plaintiffs contend manufacturers failed to sufficiently warn about Paraquat risks during handling.

Expert witnesses were proposed to validate the Paraquat-Parkinson’s link, citing research indicating Paraquat's potential to induce the disease. However, manufacturers refute these assertions, maintaining the herbicide's safety.

All federal Paraquat lawsuits are centralized in the Southern District of Illinois as multidistrict litigation. Bellwether trials, intended to predict jury responses, are crucial components of this process.

During the Paraquat “Daubert” hearings, the Judge evaluated the proposed expert testimony's reliability. Defendants sought the exclusion of an epidemiologist and statistician from Cornell University, pivotal in establishing causation in four bellwether cases.

In a subsequent memorandum and order, the Judge sided with the defendants, excluding the expert testimony due to insufficient evidence linking Paraquat to Parkinson’s disease. As this expert was key to plaintiffs’ causation arguments, all four bellwether trials were dismissed.

This ruling underscores the litigation’s complexity and the challenges associated with proving causation in Paraquat-related Parkinson’s disease cases. While these developments represent setbacks for plaintiffs, the legal process continues, with further proceedings expected in the multidistrict litigation.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Court Approves $700M Opioid Settlement for Acute Hospitals

Categories: Opioids

A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.

The settlement consolidates four separate agreements involving major drug…

Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B

Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.

The breakdown of the foam in these machines may release harmful chemicals, raising serious…

Texas Trial to Decide J&J’s $10B Talcum Powder Settlement

Categories: Talcum

A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…

🎁 March VIP Medical Record Review Offer – Get 300 Pages Free!         
Includes a Free Life Care Plan Report + 10% Off Future Reviews!

Only 15 Firms Accepted.